ClinicalTrials.gov
ClinicalTrials.gov Menu

Human Milk Cream as a Caloric Supplement in Pre-Term Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01487928
Recruitment Status : Completed
First Posted : December 8, 2011
Last Update Posted : June 1, 2018
Sponsor:
Collaborator:
Prolacta Bioscience
Information provided by (Responsible Party):
Amy Hair, Baylor College of Medicine

Brief Summary:
Human milk is commonly considered to have 20 calories per ounce (kcal/oz). However, studies show that up to 65% of human milk may be less than the expected 20 kcal/oz which can greatly affect an infant's growth. The investigators now have the ability to measure caloric density of human milk and add human milk cream to any human milk (mother's own or donor human milk) that is less than 20 kcal/oz to bring it up to that amount.

Condition or disease Intervention/treatment Phase
Prematurity Dietary Supplement: Human Milk Cream Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 78 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Randomized Study of the Use of Human Milk Cream as a Caloric Supplement in a Subset of Very Low Birth Weight Pre-Term Infants
Study Start Date : December 2011
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Human Milk Cream Group
For infants randomized to the human milk cream group, the human milk (either mother's own or donor) being provided to the infant will be tested each time a new container is used to prepare feedings. The test will be for the caloric content of the milk using a commercially available device provided for this purpose. If the caloric level falls below 20 kcal/oz for any test, then an appropriate amount of human milk cream will be added to the milk to bring the content as close as possible to 20 kcal/oz. The amount added will be calculated to the nearest mL rounding down for 0.1-0.4mL and up for 0.5-0.9 mL to avoid imprecision due to the measuring device used in the nutrition preparation area.
Dietary Supplement: Human Milk Cream
If the caloric level of human milk (mother's own or donor) falls below 20 kcal/oz, then an appropriate amount of human milk cream will be added to the milk to bring the content as close as possible to 20 kcal/oz. For example, if the human milk is 19 kcal/oz, 2 mL of human milk cream will be added to 100mL of human milk.

No Intervention: Control Group
For infants randomized to the Control group, human milk and human milk derived fortifier will be provided according to the institutional standard of care and there will be no use of the milk analysis (mother's own or donor), which is typical for the vast majority of neonatal intensive care units.



Primary Outcome Measures :
  1. Caloric content of human milk [ Time Frame: Daily until 36 weeks corrected gestational age ]
    Human milk samples will be analyzed for macronutrients and total caloric content.


Secondary Outcome Measures :
  1. Growth [ Time Frame: Weekly until 36 weeks corrected age ]
    Growth (weight, length, and head circumference) will be evaluated weekly throughout the study



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 21 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Birth weight 750 - 1250g
  • Able to adhere to expected feeding protocol of mother's own milk/donor milk with fortification of Prolacta® fortifier
  • Reasonable expectation of survival
  • Enteral feeding must begin before the 21st day of life

Exclusion Criteria:

  • Decision to not start minimum enteral feed before day 21 of life
  • Unable to obtain informed consent from parent/guardian prior to the initiation of fortification of enteral feeding
  • Enrolled in any other clinical study affecting nutritional management during the study period
  • Presence of clinically significant congenital heart disease or major congenital malformations
  • Reasonable potential for early transfer to a non-study institution

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01487928


Locations
United States, Texas
Baylor College of Medicine / Texas Children's Hospital
Houston, Texas, United States, 77030
UT Health Science Center, San Antonio
San Antonio, Texas, United States, 78229
Sponsors and Collaborators
Baylor College of Medicine
Prolacta Bioscience
Investigators
Principal Investigator: Amy B Hair, MD Baylor College of Medicine

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Amy Hair, Assistant Professor of Pediatrics, Baylor College of Medicine
ClinicalTrials.gov Identifier: NCT01487928     History of Changes
Other Study ID Numbers: H-29743
First Posted: December 8, 2011    Key Record Dates
Last Update Posted: June 1, 2018
Last Verified: May 2018

Keywords provided by Amy Hair, Baylor College of Medicine:
breastfed
human milk cream
human milk fat
caloric supplement